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Differentiation tied to inflammation
Formation of the epidermal barrier involves the differentiation 
of keratinocytes, and this process is associated with the expres-
sion of many genes in the epidermal differentiation complex. 
Upon disruption of the epidermal barrier, these keratinocytes 
produce cytokines and chemokines to induce inflammation 
and recruitment of leukocytes to the skin. Hwang and col-
leagues recently generated mice with knockout of distal-less 3 
(Dlx3) in a conditional and epidermis-specific manner in order 
to examine the role of this homeobox transcription factor in 
skin homeostasis. Delayed acquisition of barrier function was 
observed in these mice, and differentiation defects and hyper-
plasia were shown by gene expression profiles of skin from 
these mice. Not only are inflammatory IL-17-expressing T cells 
and leukocytes increased in the skin of these mice, but the gene 
expression signature of the skin from these mice shares similari-
ties with the human inflammatory skin disease psoriasis. Thus, 
Dlx3 appears to be a critical regulator of epidermal homeosta-
sis and barrier function as well as of skin inflammation. (Proc 
Natl Acad Sci USA 108:11566–71, 2011) Selected by L. Beck
Treating oncogenic addiction
Melanomas from mucosal, acral, and chronically sun-dam-
aged sites often have amplifications or activating mutations 
of KIT, the gene encoding the type III transmembrane recep-
tor tyrosine kinase KIT. To explore the effects of inhibition of 
KIT in a molecularly selected subgroup of patients with mela-
nomas harboring KIT mutations/amplifications, Carvajal and 
colleagues tested the small-molecule KIT inhibitor imatinib 
mesylate in a single-group, open-label phase II trial of 28 
selected patients. Durable responses were observed in 16% 
of the patients, and these responses lasted for more than one 
year. Thus, imatinib mesylate therapy in patients harboring 
specific KIT alterations results in clinical responses, and this 
observation is in agreement with the notion of oncogene 
addiction. These findings may ultimately lead to prediction of 
response to KIT inhibition based on selective molecular crite-
ria and, consequently, to better melanoma treatment. (JAMA 
305:2327–34, 2011) Selected by P. Bergstresser
Setting the trap
The pathophysiology of the IL-23/IL-17 axis is important in 
autoinflammatory diseases such as psoriasis. In addition to T 
helper type 17 cells, diverse types of innate immune cells such 
as mast cells and neutrophils can also produce IL-17, which 
facilitates antimicrobial activity via the formation of extracel-
lular trap (ET) structures. Lin and colleagues recently detected 
increased numbers of mast cells and neutrophils in psoriasis 
lesions and determined that these cells contribute to IL-17 
release through the formation of ET because mast cells read-
ily formed ETs and released IL-17 in skin explants treated with 
IL-23 and IL-1β. These results indicate the presence of a novel 
mechanism that drives ET-osis and IL-17 release. Furthermore, 
these results highlight an important role for mast cells and neu-
trophils in psoriasis and other autoinflammatory diseases driv-
en by the IL-23/IL-17 axis via a mechanism that involves the 
release of IL-17 through ET formation. (J Immunol 187:490–
500, 2011) Selected by P. Bergstresser
Surprising genetic differences
The notion that the sequence of mRNA reflects the sequence of 
DNA, aside from errors of transcription and changes induced 
by RNA editing, has long been the basis for genetic studies. 
Exciting new research from Li and colleagues, however, identi-
fied 28,766 events over 10,000 exonic sites in immortalized B 
cells that differed between the RNA and corresponding DNA 
sequence. Interestingly, all 12 possible categories of changes 
were identified, and 43% of these were transversions, which 
cannot be explained by typical RNA editing mechanisms. 
These variants were nonrandom—identical changes were 
found in more than one sample and individual. In addition, 
mass spectrometric analysis revealed peptide sequences in 
accord with the RNA variant sequences, supporting the bio-
logical significance of these findings. In addition to altering 
our perception of genetic variation, these results also point to 
unknown aspects of transcription or posttranscriptional RNA 
processing. (Science 333:53–8, 2011) Selected by L. Beck
Regulatory regulators
Chromatin-remodeling components and transcription factors 
must be tightly regulated to carry out the programs of devel-
opment. Fessing and colleagues recently investigated the 
mechanisms of the p63 transcription factor, which is a master 
regulator of epidermal differentiation. During epidermal mor-
phogenesis, p63 was found to directly bind and regulate the 
expression of the genome organizer Satb1, a known recruiter 
of chromatin-remodeling enzymes and transcription factors in 
tissue-specific gene expression programs. Importantly, these 
studies revealed that Satb1 remodels the chromatin architec-
ture in keratinocytes at the epidermal differentiation complex 
(EDC) locus. Furthermore, loss of Satb1 resulted in decompres-
sion at the central domain of the EDC locus, and this change 
was associated with decreased expression of terminal differ-
entiation genes and epidermal alterations. Importantly, restora-
tion of Sat1b levels in p63-deficient mice partially restored the 
epidermal phenotype in these mice, suggesting that Satb1 is 
an important regulator of the p63-specific epidermal develop-
mental program. Together, these data support a link between 
the master regulator p63 and the higher-order chromatin 
remodeling factor Satb1 in epidermal morphogenesis. (J Cell 
Biol 194:825–39, 2011) Selected by S. Yuspa
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